Related Experiment Video

Updated: Aug 8, 2026

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

S100B and cardiac surgery: possibilities and limitations

Henrik Jönsson1

  • 1Department of Cardiothoracic Surgery, University Hospital Lund, SE-221 85 Lund, Sweden. henrik.jonsson@thorax.lu.se

Restorative Neurology and Neuroscience
|October 8, 2003
PubMed

Insights

Serum glial protein S100B levels correlate with brain damage and long-term outcomes after cardiac surgery. Later S100B measurements predict survival, while early levels show less correlation due to potential blood contamination.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Cardiology

Background:

  • Serum S100B protein is a potential biomarker for brain injury.
  • Cardiac surgery can lead to neurological complications.

Purpose of the Study:

  • To investigate the correlation between S100B levels and brain damage/outcomes post-cardiac surgery.
  • To evaluate S100B as a predictor of neurological injury and survival.

Main Methods:

  • Serum S100B levels were measured at various time points after cardiac surgery.
  • Correlations were analyzed between S100B levels and indicators of brain damage (infarction) and cognitive decline.
  • Long-term survival data was compared with S100B levels.

Main Results:

  • Elevated S100B levels 48 hours post-surgery correlated with brain infarction presence and extent.
  • Higher S100B levels predicted decreased long-term survival.
  • Early S100B measurements (2-8 hours) showed inconsistent correlation with cognitive decline, possibly due to blood contamination.

Conclusions:

  • Serum S100B is a valuable biomarker for detecting brain damage and predicting outcomes after cardiac surgery.
  • Timing of S100B measurement is crucial for accurate correlation with neurological complications.
  • Further research is needed to clarify the role of early S100B measurements.

More Related Videos

Creation of Patient-Specific Silicone Cardiac Models with Applications in Pre-surgical Plans and Hands-on Training09:15

Creation of Patient-Specific Silicone Cardiac Models with Applications in Pre-surgical Plans and Hands-on Training

Published on: February 10, 2022

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft05:25

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft

Published on: September 15, 2023

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...